Once weekly subcutaneous injection of TransCon hGH

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
78	下垂体前葉機能低下症	1

78. 下垂体前葉機能低下症

臨床試験数 : 492 / 薬物数 : 341 - (DrugBank : 47) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 100

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02781727 (ClinicalTrials.gov)	December 13, 2016	19/5/2016	A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in ...	A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigatin ...	Growth Hormone Deficiency, Pediatric;hGH (Human Growth Hormone);Endocrine System Diseases;Hormones;P ...	Drug: Once weekly subcutaneous injection of TransCon hGH;Drug: Once daily subcutaneous injection of ...	Ascendis Pharma Endocrinology Division A/S	NULL	Completed	3 Years	12 Years	All	161	Phase 3	United States;Armenia;Australia;Belarus;Bulgaria;Georgia;Greece;Italy;New Zealand;Poland;Romania;Rus ...

First Previous1Next Last